Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?
Open Access
- 1 January 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 48 (S1) , S3-S13
Abstract
Antiviral agents for the treatment of influenza are urgently needed to circumvent the limitations of current drugs in several critical areas: high frKeywords
This publication has 62 references indexed in Scilit:
- Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in MiceAntimicrobial Agents and Chemotherapy, 2008
- Oseltamivir Is Adequately Absorbed Following Nasogastric Administration to Adult Patients with Severe H5N1 InfluenzaPLOS ONE, 2008
- Current and future antiviral therapy of severe seasonal and avian influenzaAntiviral Research, 2008
- Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)Virology, 2008
- Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, CanadaClinical Infectious Diseases, 2007
- Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 InfluenzaPLOS Medicine, 2007
- Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in MiceAntimicrobial Agents and Chemotherapy, 2007
- WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virusThe Lancet Infectious Diseases, 2007
- Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2006
- Avian Influenza A (H5N1) Infection in HumansNew England Journal of Medicine, 2005